State Street’s Oric Pharmaceuticals ORIC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $16.6M | Sell |
1,632,116
-564,433
| -26% | -$5.73M | ﹤0.01% | 2291 |
|
2025
Q1 | $12.3M | Buy |
2,196,549
+350,287
| +19% | +$1.95M | ﹤0.01% | 2399 |
|
2024
Q4 | $14.9M | Sell |
1,846,262
-91,907
| -5% | -$742K | ﹤0.01% | 2392 |
|
2024
Q3 | $19.9M | Sell |
1,938,169
-318,059
| -14% | -$3.26M | ﹤0.01% | 2207 |
|
2024
Q2 | $16M | Buy |
2,256,228
+540,147
| +31% | +$3.82M | ﹤0.01% | 2285 |
|
2024
Q1 | $23.6M | Buy |
1,716,081
+923,007
| +116% | +$12.7M | ﹤0.01% | 2121 |
|
2023
Q4 | $7.3M | Buy |
793,074
+74,060
| +10% | +$681K | ﹤0.01% | 2751 |
|
2023
Q3 | $4.35M | Sell |
719,014
-14,598
| -2% | -$88.3K | ﹤0.01% | 2985 |
|
2023
Q2 | $5.69M | Buy |
733,612
+623,532
| +566% | +$4.84M | ﹤0.01% | 2934 |
|
2023
Q1 | $627K | Hold |
110,080
| – | – | ﹤0.01% | 3669 |
|
2022
Q4 | $648K | Hold |
110,080
| – | – | ﹤0.01% | 3674 |
|
2022
Q3 | $352K | Hold |
110,080
| – | – | ﹤0.01% | 3907 |
|
2022
Q2 | $493K | Sell |
110,080
-483,469
| -81% | -$2.17M | ﹤0.01% | 3829 |
|
2022
Q1 | $3.17M | Sell |
593,549
-678,279
| -53% | -$3.62M | ﹤0.01% | 3389 |
|
2021
Q4 | $18.7M | Buy |
1,271,828
+211,929
| +20% | +$3.12M | ﹤0.01% | 2521 |
|
2021
Q3 | $22.2M | Sell |
1,059,899
-192,014
| -15% | -$4.01M | ﹤0.01% | 2406 |
|
2021
Q2 | $22.1M | Sell |
1,251,913
-113,652
| -8% | -$2.01M | ﹤0.01% | 2444 |
|
2021
Q1 | $33.5M | Buy |
1,365,565
+1,006,522
| +280% | +$24.7M | ﹤0.01% | 2027 |
|
2020
Q4 | $12.2M | Buy |
359,043
+238,723
| +198% | +$8.08M | ﹤0.01% | 2516 |
|
2020
Q3 | $3.01M | Buy |
120,320
+22,329
| +23% | +$558K | ﹤0.01% | 3033 |
|
2020
Q2 | $3.31M | Buy |
+97,991
| New | +$3.31M | ﹤0.01% | 2971 |
|